Reduction in Staphylococcus aureus bacteraemia rates in patients receiving haemodialysis following alteration of skin antisepsis procedures

• Published in: The Journal of hospital infection Vol. 92; no. 2; pp. 191 - 193
• Main Authors: Stewart, B.J, Gardiner, T, Perry, G.J, Tong, S.Y.C
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.02.2016
• Subjects: Anti-Infective Agents, Local - administration & dosage; Antisepsis - methods; ANZDATA; Arteriovenous fistula; Australia - epidemiology; Bacteremia - epidemiology; Bacteremia - microbiology; Bacteremia - prevention & control; Catheter-Related Infections - epidemiology; Catheter-Related Infections - microbiology; Catheter-Related Infections - prevention & control; Central venous catheter; Chlorhexidine; Chlorhexidine - administration & dosage; Haemodialysis; Hospitals; Humans; Infectious Disease; Renal Dialysis - adverse effects; Retrospective Studies; Skin - microbiology; Staphylococcal Infections - epidemiology; Staphylococcal Infections - microbiology; Staphylococcal Infections - prevention & control; Staphylococcus aureus; Staphylococcus aureus - isolation & purification; Australia; Central venous catheter; Arteriovenous fistula; Chlorhexidine; Haemodialysis; ANZDATA; Staphylococcus aureus

Summary This study examined all cases of Staphylococcus aureus bacteraemia (SAB) in the haemodialysis cohort at the Royal Darwin Hospital, Australia over a seven-year period. Midway through this period, antisepsis for arteriovenous fistulae (AVF) and central venous catheters (CVC) changed from 0.5%...